These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10527688)

  • 1. Peptide T blocks GP120/CCR5 chemokine receptor-mediated chemotaxis.
    Redwine LS; Pert CB; Rone JD; Nixon R; Vance M; Sandler B; Lumpkin MD; Dieter DJ; Ruff MR
    Clin Immunol; 1999 Nov; 93(2):124-31. PubMed ID: 10527688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR5 has an expanded ligand-binding repertoire and is the primary receptor used by MCP-2 on activated T cells.
    Ruffing N; Sullivan N; Sharmeen L; Sodroski J; Wu L
    Cell Immunol; 1998 Nov; 189(2):160-8. PubMed ID: 9790730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. I-TAC/CXCL11 is a natural antagonist for CCR5.
    Petkovic V; Moghini C; Paoletti S; Uguccioni M; Gerber B
    J Leukoc Biol; 2004 Sep; 76(3):701-8. PubMed ID: 15178708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
    Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
    J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the chemotactic peptide receptor FPRL1 in monocytes phosphorylates the chemokine receptor CCR5 and attenuates cell responses to selected chemokines.
    Shen W; Proost P; Li B; Gong W; Le Y; Sargeant R; Murphy PM; Van Damme J; Wang JM
    Biochem Biophys Res Commun; 2000 May; 272(1):276-83. PubMed ID: 10872839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro.
    Maeda K; Nakata H; Koh Y; Miyakawa T; Ogata H; Takaoka Y; Shibayama S; Sagawa K; Fukushima D; Moravek J; Koyanagi Y; Mitsuya H
    J Virol; 2004 Aug; 78(16):8654-62. PubMed ID: 15280474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4.
    Boutet A; Salim H; Taoufik Y; Lledo PM; Vincent JD; Delfraissy JF; Tardieu M
    Glia; 2001 May; 34(3):165-77. PubMed ID: 11329179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine receptor-5 (CCR5) is a receptor for the HIV entry inhibitor peptide T (DAPTA).
    Polianova MT; Ruscetti FW; Pert CB; Ruff MR
    Antiviral Res; 2005 Aug; 67(2):83-92. PubMed ID: 16002156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of CCR5 expression by IL-12 through induction of beta-chemokines in human T lymphocytes.
    Wang J; Guan E; Roderiquez G; Norcross MA
    J Immunol; 1999 Dec; 163(11):5763-9. PubMed ID: 10570258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization.
    Szabo I; Wetzel MA; Zhang N; Steele AD; Kaminsky DE; Chen C; Liu-Chen LY; Bednar F; Henderson EE; Howard OM; Oppenheim JJ; Rogers TJ
    J Leukoc Biol; 2003 Dec; 74(6):1074-82. PubMed ID: 12972507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding.
    Wu L; LaRosa G; Kassam N; Gordon CJ; Heath H; Ruffing N; Chen H; Humblias J; Samson M; Parmentier M; Moore JP; Mackay CR
    J Exp Med; 1997 Oct; 186(8):1373-81. PubMed ID: 9334377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors.
    Sabri F; Tresoldi E; Di Stefano M; Polo S; Monaco MC; Verani A; Fiore JR; Lusso P; Major E; Chiodi F; Scarlatti G
    Virology; 1999 Nov; 264(2):370-84. PubMed ID: 10562499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A chimeric MIP-1alpha/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors.
    Blanpain C; Buser R; Power CA; Edgerton M; Buchanan C; Mack M; Simmons G; Clapham PR; Parmentier M; Proudfoot AE
    J Leukoc Biol; 2001 Jun; 69(6):977-85. PubMed ID: 11404385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrostatic modeling of peptides derived from the V3-loop of HIV-1 gp120: implications of the interaction with chemokine receptor CCR5.
    Morikis D; Rizos AK; Spandidos DA; Krambovitis E
    Int J Mol Med; 2007 Mar; 19(3):343-51. PubMed ID: 17273779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of RANTES by extracellular parts of the CCR5 receptor.
    Duma L; Häussinger D; Rogowski M; Lusso P; Grzesiek S
    J Mol Biol; 2007 Jan; 365(4):1063-75. PubMed ID: 17101151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection.
    Yun JJ; Whiting D; Fischbein MP; Banerji A; Irie Y; Stein D; Fishbein MC; Proudfoot AE; Laks H; Berliner JA; Ardehali A
    Circulation; 2004 Feb; 109(7):932-7. PubMed ID: 14757698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis.
    Bruno R; Galastri S; Sacchi P; Cima S; Caligiuri A; DeFranco R; Milani S; Gessani S; Fantuzzi L; Liotta F; Frosali F; Antonucci G; Pinzani M; Marra F
    Gut; 2010 Apr; 59(4):513-20. PubMed ID: 19736361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A synthetic peptide derived from human immunodeficiency virus type 1 gp120 downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled receptor FPRL1/LXA4R.
    Deng X; Ueda H; Su SB; Gong W; Dunlop NM; Gao JL; Murphy PM; Wang JM
    Blood; 1999 Aug; 94(4):1165-73. PubMed ID: 10438703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new insight into the role of "old" chemotactic peptide receptors FPR and FPRL1: down-regulation of chemokine receptors CCR5 and CXCR4.
    Le Y; Shen W; Li B; Gong W; Dunlop NM; Wang JM
    Forum (Genova); 1999; 9(4):299-314. PubMed ID: 10611407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of the chemokine receptor, CCR5.
    Mueller A; Mahmoud NG; Goedecke MC; McKeating JA; Strange PG
    Br J Pharmacol; 2002 Feb; 135(4):1033-43. PubMed ID: 11861332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.